Gland Pharma's Q1 net profit jumps 47% to ₹317 crore, driven by strong revenue growth and strategic partnerships.

Gland Pharma has signed a strategic Manufacturing and Supply Agreement with a leading global pharmaceutical company for technology transfer, manufacturing and supply of sterile…

Strong performance driven by product launches and robust demand in CDMO segment, signaling a promising outlook for the fiscal year ahead